Efficacy of Autologous Hematopoietic Stem Cell Transplantation versus Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation for Follicular Lymphoma: Systematic Review and Meta-Analysis

Oncology. 2023;101(12):822-835. doi: 10.1159/000532090. Epub 2023 Aug 18.


Background: The effect of autologous hematopoietic stem cell transplantation (auto-HSCT) versus conventional chemotherapy or allogeneic hematopoietic stem cell transplantation (allo-HSCT) on the survival of patients with advanced follicular lymphoma (FL) is uncertain.

Objectives: To elucidate this, FL and HSCT were used as keywords to search in PubMed, Embase, Web of Science, and Cochrane Library databases.

Method: After data extraction and quality evaluation, a total of 13 studies were included, seven of which compared auto-HSCT with conventional chemotherapy and the other six compared allo-HSCT with auto-HSCT to the survival of FL patients.

Results: The results showed that auto-HSCT improved overall survival (OS), progression-free survival, and event-free survival of FL patients compared with conventional chemotherapy without auto-HSCT. Compared with allo-HSCT, the patients receiving auto-HSCT had longer OS and lower non-recurrent mortality.

Conclusions: Auto-HSCT can provide a survival advantage for patients with FL compared with conventional chemotherapy and allo-HSCT did not result in a survival benefit.

Keywords: Allogeneic hematopoietic stem cell transplantation; Autologous hematopoietic stem cell transplantation; Follicular lymphoma; Meta-analysis.

Publication types

  • Systematic Review
  • Meta-Analysis

MeSH terms

  • Hematopoietic Stem Cell Transplantation* / methods
  • Humans
  • Lymphoma, Follicular* / therapy
  • Retrospective Studies
  • Transplantation, Autologous
  • Transplantation, Homologous / methods